433 related articles for article (PubMed ID: 22444951)
1. Neurocognition, psychopathology, and subjective disturbances in schizophrenia: a comparison between short-term and remitted patients.
Comparelli A; De Carolis A; Corigliano V; Romano S; Kotzalidis G; Brugnoli R; Tamorri S; Curto M; Tatarelli R; Ferracuti S; Girardi P
Compr Psychiatry; 2012 Oct; 53(7):931-9. PubMed ID: 22444951
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
4. [Influence of attention on an auditory-verbal learning test in schizophrenic patients].
Huguelet P; Nicastro R; Zanello A
Encephale; 2002; 28(4):291-7. PubMed ID: 12232538
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the CogState Schizophrenia Battery and the Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Battery in assessing cognitive impairment in chronic schizophrenia.
Pietrzak RH; Olver J; Norman T; Piskulic D; Maruff P; Snyder PJ
J Clin Exp Neuropsychol; 2009 Oct; 31(7):848-59. PubMed ID: 19142774
[TBL] [Abstract][Full Text] [Related]
6. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between?
Balzan RP; Neaves A; Denson LA; Liu D; Galletly C
Cogn Neuropsychiatry; 2014; 19(6):471-84. PubMed ID: 24749790
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects.
Altshuler LL; Ventura J; van Gorp WG; Green MF; Theberge DC; Mintz J
Biol Psychiatry; 2004 Oct; 56(8):560-9. PubMed ID: 15476685
[TBL] [Abstract][Full Text] [Related]
8. Executive attention deficits in schizophrenia: putative mandatory and differential cognitive pathology domains in medicated schizophrenia patients.
Meiron O; Hermesh H; Katz N; Weizman A
Psychiatry Res; 2013 Aug; 209(1):1-8. PubMed ID: 23102537
[TBL] [Abstract][Full Text] [Related]
9. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
[TBL] [Abstract][Full Text] [Related]
10. Cognitive enhancement therapy for schizophrenia: effects of a 2-year randomized trial on cognition and behavior.
Hogarty GE; Flesher S; Ulrich R; Carter M; Greenwald D; Pogue-Geile M; Kechavan M; Cooley S; DiBarry AL; Garrett A; Parepally H; Zoretich R
Arch Gen Psychiatry; 2004 Sep; 61(9):866-76. PubMed ID: 15351765
[TBL] [Abstract][Full Text] [Related]
11. Spatial working memory and problem solving in schizophrenia: the effect of symptom stabilization with atypical antipsychotic medication.
Snyder PJ; Jackson CE; Piskulic D; Olver J; Norman T; Maruff P
Psychiatry Res; 2008 Sep; 160(3):316-26. PubMed ID: 18579217
[TBL] [Abstract][Full Text] [Related]
12. [Subjective cognition in schizophrenia].
Potvin S; Aubin G; Stip E
Encephale; 2017 Feb; 43(1):15-20. PubMed ID: 26923995
[TBL] [Abstract][Full Text] [Related]
13. Relationship between psychopathology and cognitive functioning in schizophrenia.
Bozikas VP; Kosmidis MH; Kioperlidou K; Karavatos A
Compr Psychiatry; 2004; 45(5):392-400. PubMed ID: 15332203
[TBL] [Abstract][Full Text] [Related]
14. Community dysfunction in schizophrenia: rate-limiting factors.
Bozikas VP; Kosmidis MH; Kafantari A; Gamvrula K; Vasiliadou E; Petrikis P; Fokas K; Karavatos A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):463-70. PubMed ID: 16442195
[TBL] [Abstract][Full Text] [Related]
15. [Measuring the cognitive deficit associated with schizophrenia: presentation of the MATRICS neuropsychological test battery].
Sarolta K; Pál C; István B
Neuropsychopharmacol Hung; 2007 Oct; 9(3):143-50. PubMed ID: 18399033
[TBL] [Abstract][Full Text] [Related]
16. Serum testosterone levels are related to cognitive function in men with schizophrenia.
Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW
Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072
[TBL] [Abstract][Full Text] [Related]
17. Morphological correlates to cognitive dysfunction in schizophrenia as studied with Bayesian regression.
Laywer G; Nyman H; Agartz I; Arnborg S; Jönsson EG; Sedvall GC; Hall H
BMC Psychiatry; 2006 Aug; 6():31. PubMed ID: 16901336
[TBL] [Abstract][Full Text] [Related]
18. Relationship of affect recognition with psychopathology and cognitive performance in schizophrenia.
Bozikas VP; Kosmidis MH; Anezoulaki D; Giannakou M; Karavatos A
J Int Neuropsychol Soc; 2004 Jul; 10(4):549-58. PubMed ID: 15327733
[TBL] [Abstract][Full Text] [Related]
19. Recovery in schizophrenia: focus on neurocognitive functioning.
Zaytseva Y; Gurovich IY; Goland E; Storozhakova YA
Psychiatr Danub; 2012 Sep; 24 Suppl 1():S172-5. PubMed ID: 22945216
[TBL] [Abstract][Full Text] [Related]
20. Deficits in neurocognition, theory of mind, and social functioning in patients with schizophrenic disorders: are they related?
Bâ MB; Zanello A; Varnier M; Koellner V; Merlo MC
J Nerv Ment Dis; 2008 Feb; 196(2):153-6. PubMed ID: 18277224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
